相似化合物
885273-42-7 651059-70-0 1065073-48-4欧盟法规
C&L通报上下游产品
2-甲基噁唑-4-羧酸甲酯 Ethyl 2-Methyloxazole-4-Carboxylate 76284-27-0📜2-甲基噁唑-4-羧酸甲酯置于水,Sodium Hydroxide体系中,用 甲醇 用作溶剂,化学反应 6.0H,以92%的收率获得2-甲基-5-噁唑羧酸
参考文献:偶氮羧酸与芳基卤化物的脱羧交叉偶联
标题:偶氮羧酸与芳基卤化物的脱羧交叉偶联
摘要:据报道噻唑和恶唑-5-羧酸与芳基卤的脱羧交叉偶联.在催化钯和化学计量的碳酸银的双金属体系下,可以以高收率制备各种(杂)芳基化的唑.
Doi:10.1021/ol1019597
专利信息
专利号:US-11787803-B2
优先权日:2017-09-15
标 题 :Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors
发明人:SCHILLER SHAWN E R; HERBERTZ TORSTEN; LI HONGBIN; GRAVES BRADFORD; MISCHKE STEVEN; WEST ANGELA V; DOWNING JENNIFER R; ERICSSON ANNA
权利人:FORMA THERAPEUTICS INC
摘要:The present disclosure is directed to inhibitors of the CBP/p300 family of bromodomains. The compounds can be useful in the treatment of disease or disorders associated with the inhibition of the CBP/p300 family of bromodomains. For instance, the disclosure is concerned with compounds and compositions for inhibition of the CBP/p300 family of bromodomains, methods of treating, preventing, or ameliorating diseases or disorders associated with the inhibition of CBP/p300 family of bromodomains, and methods of synthesis of these compounds.